Literature DB >> 25330295

More people die from thin melanomas (⩽1 mm) than from thick melanomas (>4 mm) in Queensland, Australia.

David C Whiteman1, Peter D Baade2, Catherine M Olsen3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25330295     DOI： 10.1038/jid.2014.452

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  12 in total

1.  Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.

Authors:  Michael Coory; Peter Baade; Joanne Aitken; Mark Smithers; G Roderick C McLeod; Ian Ring
Journal:  Cancer Causes Control       Date:  2006-02       Impact factor: 2.506

2.  Skin biopsy rates and incidence of melanoma: population based ecological study.

Authors:  H Gilbert Welch; Steven Woloshin; Lisa M Schwartz
Journal:  BMJ       Date:  2005-08-04

3.  Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006.

Authors:  Peter Baade; Xingqiong Meng; Danny Youlden; Joanne Aitken; Philippa Youl
Journal:  Int J Cancer       Date:  2011-04-20       Impact factor: 7.396

4.  The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.

Authors:  Waqas R Shaikh; Martin A Weinstock; Allan C Halpern; Susan A Oliveria; Alan C Geller; Stephen W Dusza
Journal:  Cancer Epidemiol       Date:  2012-09-18       Impact factor: 2.984

5.  Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry.

Authors:  Alan C Geller; Richard W Clapp; Arthur J Sober; Lou Gonsalves; Lloyd Mueller; Cindy L Christiansen; Waqas Shaikh; Donald R Miller
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

6.  Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics.

Authors:  E de Vries; F I Bray; A M M Eggermont; J W W Coebergh
Journal:  Eur J Cancer Prev       Date:  2004-10       Impact factor: 2.497

7.  Melanoma thickness trends in the United States, 1988-2006.

Authors:  Vincent D Criscione; Martin A Weinstock
Journal:  J Invest Dermatol       Date:  2009-10-15       Impact factor: 8.551

8.  Final version of 2009 AJCC melanoma staging and classification.

Authors:  Charles M Balch; Jeffrey E Gershenwald; Seng-Jaw Soong; John F Thompson; Michael B Atkins; David R Byrd; Antonio C Buzaid; Alistair J Cochran; Daniel G Coit; Shouluan Ding; Alexander M Eggermont; Keith T Flaherty; Phyllis A Gimotty; John M Kirkwood; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Arthur J Sober; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

9.  Recent incidence trends imply a nonmetastasizing form of invasive melanoma.

Authors:  R C Burton; B K Armstrong
Journal:  Melanoma Res       Date:  1994-04       Impact factor: 3.599

10.  Melanoma incidence and mortality in Scotland 1979-2003.

Authors:  R M MacKie; C Bray; J Vestey; V Doherty; A Evans; D Thomson; M Nicolson
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640
View more
  41 in total

1.  Miscoding of Melanoma Thickness in SEER: Research and Clinical Implications.

Authors:  Phyllis A Gimotty; Ronald Shore; Nancy L Lozon; Jeanne Whitlock; Sidan He; Fawn D Vigneau; Lois Dickie; David E Elder; Xiaowei Xu; Ann G Schwartz; DuPont Guerry
Journal:  J Invest Dermatol       Date:  2016-06-25       Impact factor: 8.551

2.  Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram.

Authors:  Andrea Maurichi; Rosalba Miceli; Hanna Eriksson; Julia Newton-Bishop; Jérémie Nsengimana; May Chan; Andrew J Hayes; Kara Heelan; David Adams; Roberto Patuzzo; Francesco Barretta; Gianfranco Gallino; Catherine Harwood; Daniele Bergamaschi; Dorothy Bennett; Konstantinos Lasithiotakis; Paola Ghiorzo; Bruna Dalmasso; Ausilia Manganoni; Francesca Consoli; Ilaria Mattavelli; Consuelo Barbieri; Andrea Leva; Umberto Cortinovis; Vittoria Espeli; Cristina Mangas; Pietro Quaglino; Simone Ribero; Paolo Broganelli; Giovanni Pellacani; Caterina Longo; Corrado Del Forno; Lorenzo Borgognoni; Serena Sestini; Nicola Pimpinelli; Sara Fortunato; Alessandra Chiarugi; Paolo Nardini; Elena Morittu; Antonio Florita; Mara Cossa; Barbara Valeri; Massimo Milione; Giancarlo Pruneri; Odysseas Zoras; Andrea Anichini; Roberta Mortarini; Mario Santinami
Journal:  J Clin Oncol       Date:  2020-03-13       Impact factor: 44.544

3.  Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival.

Authors:  Wei Dai; Hongliang Liu; Xinyuan Xu; Jie Ge; Sheng Luo; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Xin Li; Hongmei Nan; Chunying Li; Qingyi Wei
Journal:  Int J Cancer       Date:  2019-02-20       Impact factor: 7.396

4.  Focus on early detection to reduce melanoma deaths.

Authors:  Alan C Geller; Susan M Swetter; Martin A Weinstock
Journal:  J Invest Dermatol       Date:  2015-04       Impact factor: 8.551

5.  Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.

Authors:  Alexander M M Eggermont; Domenico Bellomo; Suzette M Arias-Mejias; Enrica Quattrocchi; Sindhuja Sominidi-Damodaran; Alina G Bridges; Julia S Lehman; Tina J Hieken; James W Jakub; Dennis H Murphree; Mark R Pittelkow; Jason C Sluzevich; Mark A Cappel; Sanjay P Bagaria; Charles Perniciaro; Félicia J Tjien-Fooh; Barbara Rentroia-Pacheco; Renske Wever; Martin H van Vliet; Jvalini Dwarkasing; Alexander Meves
Journal:  Eur J Cancer       Date:  2020-10-05       Impact factor: 9.162

Review 6.  Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.

Authors:  Douglas Grossman; Nwanneka Okwundu; Edmund K Bartlett; Michael A Marchetti; Megan Othus; Daniel G Coit; Rebecca I Hartman; Sancy A Leachman; Elizabeth G Berry; Larissa Korde; Sandra J Lee; Menashe Bar-Eli; Marianne Berwick; Tawnya Bowles; Elizabeth I Buchbinder; Elizabeth M Burton; Emily Y Chu; Clara Curiel-Lewandrowski; Julia A Curtis; Adil Daud; Dekker C Deacon; Laura K Ferris; Jeffrey E Gershenwald; Kenneth F Grossmann; Siwen Hu-Lieskovan; John Hyngstrom; Joanne M Jeter; Robert L Judson-Torres; Kari L Kendra; Caroline C Kim; John M Kirkwood; David H Lawson; Philip D Leming; Georgina V Long; Ashfaq A Marghoob; Janice M Mehnert; Michael E Ming; Kelly C Nelson; David Polsky; Richard A Scolyer; Eric A Smith; Vernon K Sondak; Mitchell S Stark; Jennifer A Stein; John A Thompson; John F Thompson; Suraj S Venna; Maria L Wei; Susan M Swetter
Journal:  JAMA Dermatol       Date:  2020-09-01       Impact factor: 10.282

7.  Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.

Authors:  Kathleen Conway; Sharon N Edmiston; Joel S Parker; Pei Fen Kuan; Yi-Hsuan Tsai; Pamela A Groben; Daniel C Zedek; Glynis A Scott; Eloise A Parrish; Honglin Hao; Michelle V Pearlstein; Jill S Frank; Craig C Carson; Matthew D Wilkerson; Xiaobei Zhao; Nathaniel A Slater; Stergios J Moschos; David W Ollila; Nancy E Thomas
Journal:  J Invest Dermatol       Date:  2018-12-06       Impact factor: 8.551

Review 8.  Review of diagnostic, prognostic, and predictive biomarkers in melanoma.

Authors:  Jacob S Ankeny; Brian Labadie; Jason Luke; Eddy Hsueh; Jane Messina; Jonathan S Zager
Journal:  Clin Exp Metastasis       Date:  2018-05-02       Impact factor: 5.150

9.  Acral Lentiginous Histologic Subtype and Sentinel Lymph Node Positivity in Thin Melanoma.

Authors:  Andrew J Marek; Michael E Ming; Edmund K Bartlett; Giorgos C Karakousis; Emily Y Chu
Journal:  JAMA Dermatol       Date:  2016-07-01       Impact factor: 10.282

Review 10.  Oncolytic Viruses for the Treatment of Metastatic Melanoma.

Authors:  Megan H Trager; Larisa J Geskin; Yvonne M Saenger
Journal:  Curr Treat Options Oncol       Date:  2020-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.